Literature DB >> 18353957

Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

Ivan Stratov1, Amy Chung, Stephen J Kent.   

Abstract

Antibody-dependent cellular cytotoxicity (ADCC) is a potentially effective adaptive immune response to human immunodeficiency virus (HIV) infection. The study of ADCC responses has been hampered by the lack of simple methods to quantify these responses and map effective epitopes. We serendipitously observed that standard intracellular cytokine assays on fresh whole blood from a cohort of 26 HIV-infected subjects identified non-T lymphocytes expressing gamma interferon (IFN-gamma) in response to overlapping linear peptides spanning HIV-1 proteins. The effector cells were CD3(-) CD4(-) CD8(-) CD14(-) CD2(+) CD56(+/-) NK lymphocytes and degranulated granzyme B and perforin in response to antigen stimulation. Serum transfer assays demonstrated that the specific response was mediated by immunoglobulin G. Fresh blood samples from half of the HIV-infected cohort demonstrated robust HIV peptide-specific IFN-gamma expression by NK cells, predominately to Env, Pol, and Vpu HIV-1 proteins. Responses were readily mapped to define minimal epitopes utilizing this assay. Antibody-dependent, HIV-specific NK cell recognition, involving components of both innate and adaptive immune systems, represents a potentially effective immune response to induce by vaccination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353957      PMCID: PMC2395196          DOI: 10.1128/JVI.01952-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

Review 2.  The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.

Authors:  Stephan Bour; Klaus Strebel
Journal:  Microbes Infect       Date:  2003-09       Impact factor: 2.700

3.  Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS.

Authors:  Nia D Banks; Nicole Kinsey; Janice Clements; James E K Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  2002-11-01       Impact factor: 2.205

4.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

Review 5.  Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1.

Authors:  David R Hout; Ellyn R Mulcahy; Erik Pacyniak; Lisa M Gomez; Melissa L Gomez; Edward B Stephens
Journal:  Curr HIV Res       Date:  2004-07       Impact factor: 1.581

6.  Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface.

Authors:  Takeshi Yamada; Nobukazu Watanabe; Tetsuya Nakamura; Aikichi Iwamoto
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

7.  Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users.

Authors:  Daniel Scott-Algara; Lien X Truong; Pierre Versmisse; Annie David; Tram T Luong; Ngai V Nguyen; Ioannis Theodorou; Françoise Barré-Sinoussi; Gianfranco Pancino
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 8.  HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity.

Authors:  Ali Ahmad; Rasheed Ahmad
Journal:  Curr HIV Res       Date:  2003-07       Impact factor: 1.581

9.  Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia.

Authors:  S Kottilil; K Shin; M Planta; M McLaughlin; C W Hallahan; M Ghany; T-W Chun; M C Sneller; A S Fauci
Journal:  J Infect Dis       Date:  2004-03-16       Impact factor: 5.226

10.  Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.

Authors:  Domenico Mavilio; Janet Benjamin; Marybeth Daucher; Gabriella Lombardo; Shyam Kottilil; Marie A Planta; Emanuela Marcenaro; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-25       Impact factor: 11.205

View more
  59 in total

1.  Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Nirmal Ganguly; Linqi Zhang; Hiko Tamashiro; David A Cooper; Mean Chhi Vun; Budiman Bela; Rossana Ditangco; Nguyen Van Kinh; Alan Bernstein; Saladin Osmanov; Bonnie Mathieson; Stephen J Kent; Yiming Shao
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

2.  A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Authors:  Diego A Vargas-Inchaustegui; Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Authors:  Caroline T Tiemessen; Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Maria A Papathanasopoulos; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

4.  HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.

Authors:  Lifei Yang; Yufeng Song; Xiaomin Li; Xiaoxing Huang; Jingjing Liu; Heng Ding; Ping Zhu; Paul Zhou
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

5.  Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.

Authors:  Amy W Chung; Jenniffer M Mabuka; Bongiwe Ndlovu; Anna Licht; Hannah Robinson; Yathisha Ramlakhan; Musie Ghebremichael; Tarylee Reddy; Philip J R Goulder; Bruce D Walker; Thumbi Ndung'u; Galit Alter
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

6.  Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure.

Authors:  Amy W Chung; Gamze Isitman; Marjon Navis; Marit Kramski; Rob J Center; Stephen J Kent; Ivan Stratov
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

Review 7.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

8.  Activation of NK cells by ADCC responses during early HIV infection.

Authors:  Amy W Chung; Marjon Navis; Gamze Isitman; Rob Centre; Robert Finlayson; Mark Bloch; Linda Gelgor; Antony Kelleher; Stephen J Kent; Ivan Stratov
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

9.  HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Authors:  Vijaya Madhavi; Bruce D Wines; Janaki Amin; Sean Emery; Ester Lopez; Anthony Kelleher; Rob J Center; P Mark Hogarth; Amy W Chung; Stephen J Kent; Ivan Stratov
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

10.  Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

Authors:  Wen Shi Lee; Jonathan Richard; Marit Lichtfuss; Amos B Smith; Jongwoo Park; Joel R Courter; Bruno N Melillo; Joseph G Sodroski; Daniel E Kaufmann; Andrés Finzi; Matthew S Parsons; Stephen J Kent
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.